Human bocavirus in children hospitalized for acute respiratory tract infection in Rome.


Journal

World journal of pediatrics : WJP
ISSN: 1867-0687
Titre abrégé: World J Pediatr
Pays: Switzerland
ID NLM: 101278599

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 18 02 2019
accepted: 01 11 2019
pubmed: 30 11 2019
medline: 24 9 2020
entrez: 29 11 2019
Statut: ppublish

Résumé

The role of human bocavirus (HBoV) as a respiratory pathogen has not been fulfilled yet. We aimed to describe clinical and serological characteristics of children with HBoV hospitalized for acute respiratory tract infection and to evaluate whether differences occur between HBoV alone and in co-infection. We retrospectively reviewed data from 60 children (median age of 6.2 months, range 0.6-70.9) hospitalized for acute respiratory symptoms, with HBoV detected from a respiratory sample, using a reverse transcriptase-PCR for 14 respiratory viruses (including respiratory syncytial virus (RSV), influenza virus A and B, human coronavirus OC43, 229E, NL-63 and HUK1, adenovirus, rhinovirus, parainfluenza virus1-3, and human metapneumovirus). HBoV was detected alone in 29 (48.3%) patients, while in co-infection with other viruses in 31 patients (51.7%), with a peak between December and January. Among the 60 patients, 34 were bronchiolitis, 19 wheezing, 3 pneumonia, 2 upper respiratory tract infection, and 2 whooping cough. Seven children (11.6%) required admission to the paediatric intensive care unit (PICU) for respiratory failure. No differences was observed in age, family history for atopy and/or asthma, clinical presentations, chest X-ray, or laboratory findings in children with HBoV alone vs. multiple viral detection. RSV was the most frequently co-detected virus (61.3%). When compared with HBoV detection alone, the co-detection of RSV and HBoV was associated with male sex (P = 0.013), younger age (P = 0.01), and lower blood neutrophil count (P = 0.032). HBoV can be detected alone and in co-infection respiratory samples of children with an acute respiratory tract infection. A cause-effect relationship between HBoV and respiratory infection is not clear, so further studies are needed to clarify this point.

Sections du résumé

BACKGROUND BACKGROUND
The role of human bocavirus (HBoV) as a respiratory pathogen has not been fulfilled yet. We aimed to describe clinical and serological characteristics of children with HBoV hospitalized for acute respiratory tract infection and to evaluate whether differences occur between HBoV alone and in co-infection.
METHODS METHODS
We retrospectively reviewed data from 60 children (median age of 6.2 months, range 0.6-70.9) hospitalized for acute respiratory symptoms, with HBoV detected from a respiratory sample, using a reverse transcriptase-PCR for 14 respiratory viruses (including respiratory syncytial virus (RSV), influenza virus A and B, human coronavirus OC43, 229E, NL-63 and HUK1, adenovirus, rhinovirus, parainfluenza virus1-3, and human metapneumovirus).
RESULTS RESULTS
HBoV was detected alone in 29 (48.3%) patients, while in co-infection with other viruses in 31 patients (51.7%), with a peak between December and January. Among the 60 patients, 34 were bronchiolitis, 19 wheezing, 3 pneumonia, 2 upper respiratory tract infection, and 2 whooping cough. Seven children (11.6%) required admission to the paediatric intensive care unit (PICU) for respiratory failure. No differences was observed in age, family history for atopy and/or asthma, clinical presentations, chest X-ray, or laboratory findings in children with HBoV alone vs. multiple viral detection. RSV was the most frequently co-detected virus (61.3%). When compared with HBoV detection alone, the co-detection of RSV and HBoV was associated with male sex (P = 0.013), younger age (P = 0.01), and lower blood neutrophil count (P = 0.032).
CONCLUSIONS CONCLUSIONS
HBoV can be detected alone and in co-infection respiratory samples of children with an acute respiratory tract infection. A cause-effect relationship between HBoV and respiratory infection is not clear, so further studies are needed to clarify this point.

Identifiants

pubmed: 31776891
doi: 10.1007/s12519-019-00324-5
pii: 10.1007/s12519-019-00324-5
pmc: PMC7091143
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

293-298

Références

Ann N Y Acad Sci. 1957 Apr 19;67(8):430-8
pubmed: 13411978
Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12891-6
pubmed: 16118271
Pediatr Pulmonol. 2013 Nov;48(11):1112-8
pubmed: 23818319
Pediatr Infect Dis J. 2005 May;24(5 Suppl):S25-34
pubmed: 15876920
Lancet. 2006 Jul 22;368(9532):312-22
pubmed: 16860701
Influenza Other Respir Viruses. 2008 Sep;2(5):175-9
pubmed: 19453422
Clin Lab. 2019 Jan 1;65(1):
pubmed: 30775887
J Clin Virol. 2007 Nov;40(3):224-8
pubmed: 17904416
Arch Virol. 2015 Jan;160(1):117-27
pubmed: 25269520
Arch Dis Child. 2010 Jan;95(1):35-41
pubmed: 19822538
Pediatr Pulmonol. 2010 Jun;45(6):585-91
pubmed: 20503284
Eur Respir J. 2014 Apr;43(4):1172-7
pubmed: 24525447
J Med Virol. 2016 Dec;88(12):2052-2058
pubmed: 27124519
Arch Virol. 2018 May;163(5):1325-1330
pubmed: 29392492
J Med Virol. 2007 Apr;79(4):463-8
pubmed: 17311326
Pediatr Pulmonol. 2004 Mar;37(3):243-8
pubmed: 14966818
Thorax. 2011 Oct;66 Suppl 2:ii1-23
pubmed: 21903691
BMC Infect Dis. 2014 Jul 30;14:424
pubmed: 25078257
Clin Infect Dis. 2015 Oct 15;61(8):1217-24
pubmed: 26245665
J Infect Dis. 2010 Jun 1;201(11):1625-32
pubmed: 20415535
PLoS One. 2011 May 04;6(5):e19457
pubmed: 21573237
Pediatr Infect Dis J. 2008 Aug;27(8):677-80
pubmed: 18574440
J Infect Dis. 2010 Jun 1;201(11):1611-4
pubmed: 20415534
Pediatr Pulmonol. 2016 Dec;51(12):1330-1335
pubmed: 27228123
J Trop Pediatr. 2019 Aug 1;65(4):342-351
pubmed: 30202992
Clin Infect Dis. 2008 Feb 15;46(4):540-6
pubmed: 18199037

Auteurs

Laura Petrarca (L)

Maternal-Infantile and Urological Science Department, "Sapienza" University of Rome, Rome, Italy.

Raffaella Nenna (R)

Maternal-Infantile and Urological Science Department, "Sapienza" University of Rome, Rome, Italy.

Antonella Frassanito (A)

Maternal-Infantile and Urological Science Department, "Sapienza" University of Rome, Rome, Italy.

Alessandra Pierangeli (A)

Virology Laboratory, Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

Greta Di Mattia (G)

Maternal-Infantile and Urological Science Department, "Sapienza" University of Rome, Rome, Italy.

Carolina Scagnolari (C)

Virology Laboratory, Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

Fabio Midulla (F)

Maternal-Infantile and Urological Science Department, "Sapienza" University of Rome, Rome, Italy. midulla@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH